speb/financial-data huggingface dataset:
EPSN balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 636295.00
EPSN balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
EPSN balance_sheet (annual, 2023-12-31) — Prepaid Assets: 952301.00
EPSN income_statement (annual, 2023-12-31) — Pretax Income: 10145600.00
EPSN cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 62875.00
EPSN cash_flow (annual, 2023-12-31) — Purchase Of Investment: -44801956.00
EPSN cash_flow (annual, 2023-12-31) — Purchase Of PPE: -18646075.00
EPSN balance_sheet (annual, 2023-12-31) — Receivables: 6015448.00
EPSN income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 16550059.00
EPSN income_statement (annual, 2023-12-31) — Reconciled Depreciation: 7685084.00
EPSN cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -6055601.00
EPSN balance_sheet (annual, 2023-12-31) — Retained Earnings: -37946042.00
EPSN income_statement (annual, 2023-12-31) — Salaries And Wages: 1018262.00
EPSN cash_flow (annual, 2023-12-31) — Sale Of Investment: 26864976.00
EPSN cash_flow (annual, 2023-12-31) — Sale Of PPE: 12498.00
EPSN income_statement (annual, 2023-12-31) — Selling General And Administration: 7311496.00
EPSN balance_sheet (annual, 2023-12-31) — Share Issued: 22222722.00
EPSN income_statement (annual, 2023-12-31) — Special Income Charges: -1449871.00
EPSN cash_flow (annual, 2023-12-31) — Stock Based Compensation: 1018262.00
EPSN balance_sheet (annual, 2023-12-31) — Stockholders Equity: 100612965.00
EPSN balance_sheet (annual, 2023-12-31) — Tangible Book Value: 100612965.00
EPSN income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 529930.03
EPSN income_statement (annual, 2023-12-31) — Tax Provision: 3200447.00
EPSN income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.32
EPSN balance_sheet (annual, 2023-12-31) — Total Assets: 124042613.00
EPSN balance_sheet (annual, 2023-12-31) — Total Capitalization: 100612965.00
EPSN balance_sheet (annual, 2023-12-31) — Total Debt: 563384.00
EPSN balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 100612965.00
EPSN income_statement (annual, 2023-12-31) — Total Expenses: 23861555.00
EPSN balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 23429648.00
EPSN balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 82913817.00
EPSN balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 15533806.00
EPSN income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 5418326.00
EPSN income_statement (annual, 2023-12-31) — Total Unusual Items: 1680184.00
EPSN income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 1680184.00
EPSN balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 70874.00
EPSN balance_sheet (annual, 2023-12-31) — Treasury Stock: 360326.00
EPSN balance_sheet (annual, 2023-12-31) — Working Capital: 33232954.00
EPSN income_statement (quarterly, 2024-09-30) — Basic Average Shares: 21948519.00
EPSN income_statement (quarterly, 2024-09-30) — Basic EPS: 0.02
EPSN cash_flow (quarterly, 2024-09-30) — Change In Income Tax Payable: 0.00
EPSN cash_flow (quarterly, 2024-09-30) — Change In Tax Payable: 0.00
EPSN income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 22155292.00
EPSN income_statement (quarterly, 2024-09-30) — Diluted EPS: 0.02
EPSN cash_flow (quarterly, 2024-09-30) — Gain Loss On Sale Of PPE: 0.00
EPSN income_statement (quarterly, 2024-09-30) — Gain On Sale Of Ppe: 0.00
EPSN balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 50702.00
EPSN balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 0.00
EPSN cash_flow (quarterly, 2024-09-30) — Sale Of PPE: 0.00
EPSN balance_sheet (quarterly, 2024-09-30) — Treasury Shares Number: 125000.00
EPSN balance_sheet (quarterly, 2024-09-30) — Treasury Stock: 627500.00
EPSN income_statement (annual, 2024-12-31) — +Operating Expense: 6933130.00
EPSN income_statement (annual, 2024-12-31) — +Total Revenue: 31522775.00
EPSN balance_sheet (annual, 2024-12-31) — Accounts Payable: 2334732.00
EPSN balance_sheet (annual, 2024-12-31) — Accounts Receivable: 5806765.00
EPSN balance_sheet (annual, 2024-12-31) — Accrued Interest Receivable: 0.00
EPSN balance_sheet (quarterly, 2024-12-31) — Accrued Interest Receivable: 0.00
EPSN balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -159730906.00
EPSN balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 12118907.00
EPSN cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 1450076.00
EPSN income_statement (annual, 2024-12-31) — Basic Average Shares: 21930277.00
EPSN income_statement (annual, 2024-12-31) — Basic EPS: 0.09
EPSN cash_flow (annual, 2024-12-31) — Beginning Cash Position: 13873628.00
EPSN balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 603924.00
EPSN cash_flow (annual, 2024-12-31) — Capital Expenditure: -36560896.00
EPSN cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -4641567.00
EPSN balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 476911.00
EPSN balance_sheet (annual, 2024-12-31) — Capital Stock: 116081031.00
EPSN balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 6519793.00
EPSN balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 6519793.00
EPSN cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -5486834.00
EPSN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -7318042.00
EPSN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -16658660.00
EPSN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 16830279.00
EPSN cash_flow (annual, 2024-12-31) — Change In Account Payable: -493176.00
EPSN cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -17828.00
EPSN cash_flow (annual, 2024-12-31) — Change In Payable: -493176.00
EPSN cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -493176.00
EPSN cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -23662.00
EPSN cash_flow (annual, 2024-12-31) — Change In Receivables: 171726.00
EPSN cash_flow (annual, 2024-12-31) — Change In Working Capital: -362940.00
EPSN cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 171726.00
EPSN cash_flow (annual, 2024-12-31) — Changes In Cash: -7146423.00
EPSN balance_sheet (annual, 2024-12-31) — Common Stock: 116081031.00
EPSN cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -5486834.00
EPSN balance_sheet (annual, 2024-12-31) — Common Stock Equity: 96728129.00
EPSN cash_flow (annual, 2024-12-31) — Common Stock Payments: -1831208.00
EPSN cash_flow (quarterly, 2024-12-31) — Common Stock Payments: 0.00
EPSN income_statement (annual, 2024-12-31) — Cost Of Revenue: 19715133.00
EPSN balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 943582.00
EPSN balance_sheet (annual, 2024-12-31) — Current Assets: 14131519.00
EPSN balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 121135.00
EPSN balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 121135.00
EPSN balance_sheet (annual, 2024-12-31) — Current Liabilities: 6980007.00
EPSN cash_flow (annual, 2024-12-31) — Deferred Income Tax: 1184634.00
EPSN cash_flow (annual, 2024-12-31) — Deferred Tax: 1184634.00
EPSN cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 10185119.00
EPSN income_statement (annual, 2024-12-31) — Diluted Average Shares: 21930277.00
EPSN income_statement (annual, 2024-12-31) — Diluted EPS: 0.09
EPSN income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 1927800.00
EPSN income_statement (annual, 2024-12-31) — EBIT: 3603293.00
EPSN income_statement (annual, 2024-12-31) — EBITDA: 13788412.00
EPSN cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 262588.00
EPSN cash_flow (annual, 2024-12-31) — End Cash Position: 6989793.00
EPSN balance_sheet (annual, 2024-12-31) — Financial Assets: 0.00
EPSN balance_sheet (quarterly, 2024-12-31) — Financial Assets: 0.00
EPSN cash_flow (annual, 2024-12-31) — Financing Cash Flow: -7318042.00
EPSN cash_flow (annual, 2024-12-31) — Free Cash Flow: -19730617.00
EPSN cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 391147.00
EPSN cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
EPSN cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
EPSN income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: 0.00
EPSN income_statement (quarterly, 2024-12-31) — Gain On Sale Of Ppe: 0.00
EPSN income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -391147.00
EPSN balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 10033267.00
EPSN income_statement (annual, 2024-12-31) — General And Administrative Expense: 6933130.00
EPSN balance_sheet (annual, 2024-12-31) — Gross PPE: 264601455.00
EPSN income_statement (annual, 2024-12-31) — Gross Profit: 11807642.00
EPSN balance_sheet (annual, 2024-12-31) — Hedging Assets Current: 0.00
EPSN balance_sheet (quarterly, 2024-12-31) — Hedging Assets Current: 0.00
EPSN income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 1450076.00
EPSN cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 414250.00
EPSN income_statement (annual, 2024-12-31) — Interest Expense: 46400.00
EPSN income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 46400.00
EPSN income_statement (annual, 2024-12-31) — Interest Income: 493277.00
EPSN income_statement (annual, 2024-12-31) — Interest Income Non Operating: 493277.00
EPSN cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 16832.00
EPSN balance_sheet (annual, 2024-12-31) — Invested Capital: 96728129.00
EPSN cash_flow (annual, 2024-12-31) — Investing Cash Flow: -16658660.00
EPSN cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
EPSN balance_sheet (annual, 2024-12-31) — Land And Improvements: 637764.00
EPSN balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 355776.00
EPSN balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 355776.00
EPSN cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
EPSN balance_sheet (annual, 2024-12-31) — Long Term Provisions: 3652296.00
EPSN cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
EPSN cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -1831208.00
EPSN cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
EPSN income_statement (annual, 2024-12-31) — Net Income: 1927800.00
EPSN income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 1927800.00
EPSN income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 1927800.00
EPSN income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 1927800.00
EPSN income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 1927800.00
EPSN cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 1927800.00
EPSN income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 1927800.00
EPSN income_statement (annual, 2024-12-31) — Net Interest Income: 446877.00
EPSN cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 19071145.00
EPSN cash_flow (quarterly, 2024-12-31) — Net Investment Purchase And Sale: 0.00
EPSN cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
EPSN cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 0.00
EPSN income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 446877.00
EPSN cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 831091.00
EPSN cash_flow (quarterly, 2024-12-31) — Net Other Investing Changes: -982717.00
EPSN balance_sheet (annual, 2024-12-31) — Net PPE: 104870549.00
EPSN cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -36560896.00
EPSN balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 96728129.00
EPSN balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 0.00
EPSN balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Assets: 0.00
EPSN balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 12738577.00
EPSN balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 12738577.00
EPSN balance_sheet (annual, 2024-12-31) — Non Current Prepaid Assets: 982717.00
EPSN income_statement (annual, 2024-12-31) — Normalized EBITDA: 15629635.00
EPSN income_statement (annual, 2024-12-31) — Normalized Income: 3382366.17
EPSN cash_flow (annual, 2024-12-31) — Operating Cash Flow: 16830279.00
EPSN cash_flow (annual, 2024-12-31) — Operating Gains Losses: 391147.00
EPSN income_statement (annual, 2024-12-31) — Operating Income: 4874512.00
EPSN income_statement (annual, 2024-12-31) — Operating Revenue: 31522775.00
EPSN balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 22008766.00
EPSN balance_sheet (annual, 2024-12-31) — Other Current Assets: 792041.00
EPSN balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 487548.00
EPSN balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 487548.00
EPSN balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 10033267.00
EPSN income_statement (annual, 2024-12-31) — Other Gand A: 5688714.00
EPSN income_statement (annual, 2024-12-31) — Other Income Expense: -1764496.00
EPSN cash_flow (annual, 2024-12-31) — Other Non Cash Items: 810027.00
EPSN balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 470000.00
EPSN income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 76727.00
EPSN balance_sheet (annual, 2024-12-31) — Other Payable: 2397992.00
EPSN balance_sheet (annual, 2024-12-31) — Other Properties: 43116371.00
EPSN balance_sheet (annual, 2024-12-31) — Other Receivables: 36957.00
EPSN balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 0.00
EPSN balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 0.00
EPSN balance_sheet (annual, 2024-12-31) — Payables: 4732724.00
EPSN balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 5676306.00
EPSN balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 695018.00
EPSN balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
EPSN balance_sheet (annual, 2024-12-31) — Prepaid Assets: 975963.00
EPSN income_statement (annual, 2024-12-31) — Pretax Income: 3556893.00
EPSN cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 0.00
EPSN cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
EPSN cash_flow (annual, 2024-12-31) — Purchase Of Investment: -4045785.00
EPSN cash_flow (quarterly, 2024-12-31) — Purchase Of Investment: 0.00
EPSN cash_flow (annual, 2024-12-31) — Purchase Of PPE: -36560896.00
EPSN balance_sheet (annual, 2024-12-31) — Receivables: 5843722.00
EPSN income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 19715133.00
EPSN income_statement (annual, 2024-12-31) — Reconciled Depreciation: 10185119.00
EPSN cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -1831208.00
EPSN cash_flow (quarterly, 2024-12-31) — Repurchase Of Capital Stock: 0.00
EPSN income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
EPSN balance_sheet (annual, 2024-12-31) — Retained Earnings: -41505076.00
EPSN income_statement (annual, 2024-12-31) — Salaries And Wages: 1244416.00
EPSN cash_flow (annual, 2024-12-31) — Sale Of Investment: 23116930.00
EPSN cash_flow (quarterly, 2024-12-31) — Sale Of Investment: 0.00
EPSN cash_flow (annual, 2024-12-31) — Sale Of PPE: 0.00
EPSN cash_flow (quarterly, 2024-12-31) — Sale Of PPE: 0.00
EPSN income_statement (annual, 2024-12-31) — Selling General And Administration: 6933130.00
EPSN balance_sheet (annual, 2024-12-31) — Share Issued: 22008766.00
EPSN income_statement (annual, 2024-12-31) — Special Income Charges: -1450076.00
EPSN cash_flow (annual, 2024-12-31) — Stock Based Compensation: 1244416.00
EPSN balance_sheet (annual, 2024-12-31) — Stockholders Equity: 96728129.00
EPSN balance_sheet (annual, 2024-12-31) — Tangible Book Value: 96728129.00
EPSN income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -386656.83
EPSN income_statement (annual, 2024-12-31) — Tax Provision: 1629093.00
EPSN income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
EPSN balance_sheet (annual, 2024-12-31) — Total Assets: 120454785.00
EPSN balance_sheet (annual, 2024-12-31) — Total Capitalization: 96728129.00
EPSN balance_sheet (annual, 2024-12-31) — Total Debt: 476911.00
EPSN balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 96728129.00
EPSN income_statement (annual, 2024-12-31) — Total Expenses: 26648263.00
EPSN balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 23726656.00
EPSN balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 106323266.00
EPSN balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 16746649.00
EPSN income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 3424436.00
EPSN income_statement (annual, 2024-12-31) — Total Unusual Items: -1841223.00
EPSN income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -1841223.00
EPSN balance_sheet (annual, 2024-12-31) — Tradeand Other Payables Non Current: 0.00
EPSN balance_sheet (quarterly, 2024-12-31) — Tradeand Other Payables Non Current: 0.00
EPSN balance_sheet (annual, 2024-12-31) — Treasury Stock: 0.00
EPSN balance_sheet (quarterly, 2024-12-31) — Treasury Stock: 0.00
EPSN balance_sheet (annual, 2024-12-31) — Working Capital: 7151512.00
EPSN income_statement (quarterly, 2025-03-31) — +Operating Expense: 2204256.00
EPSN income_statement (quarterly, 2025-03-31) — +Total Revenue: 16163140.00
EPSN balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 2013172.00
EPSN balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 7972835.00
EPSN balance_sheet (quarterly, 2025-03-31) — Accrued Interest Receivable: 0.00
EPSN balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -163147224.00
EPSN balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 12504745.00
EPSN cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 6669.00
EPSN income_statement (quarterly, 2025-03-31) — Basic Average Shares: 22008766.00
EPSN income_statement (quarterly, 2025-03-31) — Basic EPS: 0.18
EPSN cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 6989793.00
EPSN balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 565498.00
EPSN cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -7744042.00
EPSN balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 447820.00
EPSN balance_sheet (quarterly, 2025-03-31) — Capital Stock: 116081031.00
EPSN balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 6892735.00
EPSN balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 6892735.00
EPSN cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -1375612.00
EPSN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -1375612.00
EPSN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -6783906.00
EPSN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 8582576.00
EPSN cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 91390.00
EPSN cash_flow (quarterly, 2025-03-31) — Change In Income Tax Payable: 922326.00
EPSN cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 141640.00
EPSN cash_flow (quarterly, 2025-03-31) — Change In Payable: 1013716.00
EPSN cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 1013716.00
EPSN cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 978542.00
EPSN cash_flow (quarterly, 2025-03-31) — Change In Receivables: -2159795.00
EPSN cash_flow (quarterly, 2025-03-31) — Change In Tax Payable: 922326.00
EPSN cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -25897.00
EPSN cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -2159795.00
EPSN cash_flow (quarterly, 2025-03-31) — Changes In Cash: 423058.00
EPSN balance_sheet (quarterly, 2025-03-31) — Common Stock: 116081031.00
EPSN cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -1375612.00
EPSN balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 99704273.00
EPSN cash_flow (quarterly, 2025-03-31) — Common Stock Payments: 0.00
EPSN income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 6784406.00
EPSN balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 791400.00
EPSN balance_sheet (quarterly, 2025-03-31) — Current Assets: 15543547.00
EPSN balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 121293.00
EPSN balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 121293.00
EPSN balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 9341333.00
EPSN cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -321452.00
EPSN cash_flow (quarterly, 2025-03-31) — Deferred Tax: -321452.00
EPSN cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 3475857.00
EPSN income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 22109819.00
EPSN income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.18
EPSN income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 4016034.00
EPSN income_statement (quarterly, 2025-03-31) — EBIT: 5698439.00
EPSN income_statement (quarterly, 2025-03-31) — EBITDA: 9174296.00
EPSN cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -50116.00
EPSN cash_flow (quarterly, 2025-03-31) — End Cash Position: 7362735.00
EPSN cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -1375612.00
EPSN cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 838534.00
EPSN cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 1462170.00
EPSN income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -1462170.00
EPSN balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 9983151.00
EPSN income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 2204256.00
EPSN balance_sheet (quarterly, 2025-03-31) — Gross PPE: 272616383.00
EPSN income_statement (quarterly, 2025-03-31) — Gross Profit: 9378734.00
EPSN income_statement (quarterly, 2025-03-31) — Impairment Of Capital Assets: 6669.00
EPSN cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 85163.00
EPSN balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 924905.00
EPSN income_statement (quarterly, 2025-03-31) — Interest Expense: 12211.00
EPSN income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 12211.00
EPSN income_statement (quarterly, 2025-03-31) — Interest Income: 15299.00
EPSN income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 15299.00
EPSN cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 657.00
EPSN balance_sheet (quarterly, 2025-03-31) — Invested Capital: 99704273.00
EPSN cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -6783906.00
EPSN balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 637764.00
EPSN balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 326527.00
EPSN balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 326527.00
EPSN balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 3716029.00
EPSN cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
EPSN income_statement (quarterly, 2025-03-31) — Net Income: 4016034.00
EPSN income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 4016034.00
EPSN income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 4016034.00
EPSN income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 4016034.00
EPSN income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 4016034.00
EPSN cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 4016034.00
EPSN income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 4016034.00
EPSN income_statement (quarterly, 2025-03-31) — Net Interest Income: 3088.00
EPSN cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 0.00
EPSN income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 3088.00
EPSN cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 960136.00
EPSN balance_sheet (quarterly, 2025-03-31) — Net PPE: 109469159.00
EPSN cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -7744042.00
EPSN balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 99704273.00
EPSN balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 12417125.00
EPSN balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 12417125.00
EPSN balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 22581.00
EPSN income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 10643135.00
EPSN income_statement (quarterly, 2025-03-31) — Normalized Income: 5053436.54
EPSN cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 8582576.00
EPSN cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 1462170.00
EPSN income_statement (quarterly, 2025-03-31) — Operating Income: 7174478.00
EPSN income_statement (quarterly, 2025-03-31) — Operating Revenue: 16163140.00
EPSN balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 22008766.00
EPSN balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 647295.00
EPSN balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 1534675.00
EPSN balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 9983151.00
EPSN income_statement (quarterly, 2025-03-31) — Other Gand A: 1818418.00
EPSN income_statement (quarterly, 2025-03-31) — Other Income Expense: -1491338.00
EPSN cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -416643.00
EPSN balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 470000.00
EPSN income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -22499.00
EPSN balance_sheet (quarterly, 2025-03-31) — Other Payable: 3670983.00
EPSN balance_sheet (quarterly, 2025-03-31) — Other Properties: 43176418.00
EPSN balance_sheet (quarterly, 2025-03-31) — Other Receivables: 30682.00
EPSN balance_sheet (quarterly, 2025-03-31) — Payables: 6609060.00
EPSN balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 7400460.00
EPSN balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 284905.00
EPSN balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
EPSN balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 0.00
EPSN income_statement (quarterly, 2025-03-31) — Pretax Income: 5686228.00
EPSN cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: 0.00
EPSN cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -7744042.00
EPSN balance_sheet (quarterly, 2025-03-31) — Receivables: 8003517.00
EPSN income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 6784406.00
EPSN income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 3475857.00
EPSN cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: 0.00
EPSN balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -38864654.00
EPSN income_statement (quarterly, 2025-03-31) — Salaries And Wages: 385838.00
EPSN cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 0.00
EPSN cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 0.00
EPSN income_statement (quarterly, 2025-03-31) — Selling General And Administration: 2204256.00
EPSN balance_sheet (quarterly, 2025-03-31) — Share Issued: 22008766.00
EPSN income_statement (quarterly, 2025-03-31) — Special Income Charges: -6669.00
EPSN cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 385838.00
EPSN balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 99704273.00
EPSN balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 99704273.00
EPSN income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -431436.46
EPSN income_statement (quarterly, 2025-03-31) — Tax Provision: 1670194.00
EPSN income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.29
EPSN balance_sheet (quarterly, 2025-03-31) — Total Assets: 125505287.00
EPSN balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 99704273.00
EPSN balance_sheet (quarterly, 2025-03-31) — Total Debt: 447820.00
EPSN balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 99704273.00
EPSN income_statement (quarterly, 2025-03-31) — Total Expenses: 8988662.00
EPSN balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 25801014.00
EPSN balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 109961740.00
EPSN balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 16459681.00
EPSN income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 7167809.00
EPSN balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 924905.00
EPSN income_statement (quarterly, 2025-03-31) — Total Unusual Items: -1468839.00
EPSN income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -1468839.00
EPSN balance_sheet (quarterly, 2025-03-31) — Working Capital: 6202214.00
EPSN income_statement (quarterly, 2025-06-30) — +Operating Expense: 1847716.00
EPSN income_statement (quarterly, 2025-06-30) — +Total Revenue: 11624733.00
EPSN balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 2018533.00
EPSN balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 5381234.00
EPSN balance_sheet (quarterly, 2025-06-30) — Accrued Interest Receivable: 0.00
EPSN balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -168956650.00
EPSN balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 12890583.00
EPSN cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 2670000.00
EPSN income_statement (quarterly, 2025-06-30) — Basic Average Shares: 22017310.00
EPSN income_statement (quarterly, 2025-06-30) — Basic EPS: 0.07
EPSN cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 7362735.00
EPSN balance_sheet (quarterly, 2025-06-30) — Buildings And Improvements: 540872.00
EPSN cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -3627029.00
EPSN balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 417307.00
EPSN balance_sheet (quarterly, 2025-06-30) — Capital Stock: 116081031.00
EPSN balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 9907653.00
EPSN balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 9907653.00
EPSN cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -1375760.00
EPSN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -1375760.00
EPSN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -3882000.00
EPSN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 8348174.00
EPSN cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -157844.00
EPSN cash_flow (quarterly, 2025-06-30) — Change In Income Tax Payable: 1650595.00
EPSN cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 243805.00
EPSN cash_flow (quarterly, 2025-06-30) — Change In Payable: 1492751.00
EPSN cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 1492751.00
EPSN cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -978542.00
EPSN cash_flow (quarterly, 2025-06-30) — Change In Receivables: 2506634.00
EPSN cash_flow (quarterly, 2025-06-30) — Change In Tax Payable: 1650595.00
EPSN cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 3264648.00
EPSN cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 2506634.00
EPSN cash_flow (quarterly, 2025-06-30) — Changes In Cash: 3090414.00
EPSN balance_sheet (quarterly, 2025-06-30) — Common Stock: 116081031.00
EPSN cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -1375760.00
EPSN balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 100190316.00
EPSN cash_flow (quarterly, 2025-06-30) — Common Stock Payments: 0.00
EPSN income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 6278234.00
EPSN balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 509463.00
EPSN balance_sheet (quarterly, 2025-06-30) — Current Assets: 16533328.00
EPSN balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 121057.00
EPSN balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 121057.00
EPSN balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 7403385.00
EPSN cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -458224.00
EPSN cash_flow (quarterly, 2025-06-30) — Deferred Tax: -458224.00
EPSN cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 3201654.00
EPSN income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 22202315.00
EPSN income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.07
EPSN income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 1551461.00
EPSN income_statement (quarterly, 2025-06-30) — EBIT: 3409054.00
EPSN income_statement (quarterly, 2025-06-30) — EBITDA: 6610708.00
EPSN cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -75496.00
EPSN cash_flow (quarterly, 2025-06-30) — End Cash Position: 10377653.00
EPSN cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -1375760.00
EPSN cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 4721145.00
EPSN cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -2573863.00
EPSN income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 2573863.00
EPSN balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 9907655.00
EPSN income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 1847716.00
EPSN balance_sheet (quarterly, 2025-06-30) — Gross PPE: 275289438.00
EPSN income_statement (quarterly, 2025-06-30) — Gross Profit: 5346499.00
EPSN balance_sheet (quarterly, 2025-06-30) — Hedging Assets Current: 732528.00
EPSN income_statement (quarterly, 2025-06-30) — Impairment Of Capital Assets: 2670000.00
EPSN cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 1596685.00
EPSN balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 1596958.00
EPSN income_statement (quarterly, 2025-06-30) — Interest Expense: 19906.00
EPSN income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 19906.00
EPSN income_statement (quarterly, 2025-06-30) — Interest Income: 17247.00
EPSN income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 17247.00
EPSN cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 8895.00
EPSN balance_sheet (quarterly, 2025-06-30) — Invested Capital: 100190316.00
EPSN cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -3882000.00
EPSN balance_sheet (quarterly, 2025-06-30) — Land And Improvements: 637764.00
EPSN balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 296250.00
EPSN balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 296250.00
EPSN balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 3764816.00
EPSN cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
EPSN income_statement (quarterly, 2025-06-30) — Net Income: 1551461.00
EPSN income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 1551461.00
EPSN income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 1551461.00
EPSN income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 1551461.00
EPSN income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 1551461.00
EPSN cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 1551461.00
EPSN income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 1551461.00
EPSN income_statement (quarterly, 2025-06-30) — Net Interest Income: -2659.00
EPSN cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 0.00
EPSN income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -2659.00
EPSN cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -254971.00
EPSN balance_sheet (quarterly, 2025-06-30) — Net PPE: 106332788.00
EPSN cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -3627029.00
EPSN balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 100190316.00
EPSN balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 11958901.00
EPSN balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 11958901.00
EPSN balance_sheet (quarterly, 2025-06-30) — Non Current Prepaid Assets: 277552.00
EPSN income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 6706845.00
EPSN income_statement (quarterly, 2025-06-30) — Normalized Income: 1627409.23
EPSN cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 8348174.00
EPSN cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -2573863.00
EPSN income_statement (quarterly, 2025-06-30) — Operating Income: 3498783.00
EPSN income_statement (quarterly, 2025-06-30) — Operating Revenue: 11624733.00
EPSN balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 22017405.00
EPSN balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 396264.00
EPSN balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 9907655.00
EPSN income_statement (quarterly, 2025-06-30) — Other Gand A: 1461878.00
EPSN income_statement (quarterly, 2025-06-30) — Other Income Expense: -106976.00
EPSN cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 306660.00
EPSN balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 470000.00
EPSN income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -10839.00
EPSN balance_sheet (quarterly, 2025-06-30) — Other Payable: 2692319.00
EPSN balance_sheet (quarterly, 2025-06-30) — Other Properties: 43416065.00
EPSN balance_sheet (quarterly, 2025-06-30) — Other Receivables: 115649.00
EPSN balance_sheet (quarterly, 2025-06-30) — Payables: 6307810.00
EPSN balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 6817273.00
EPSN balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 465055.00
EPSN balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
EPSN balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 0.00
EPSN income_statement (quarterly, 2025-06-30) — Pretax Income: 3389148.00
EPSN cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: 0.00
EPSN cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -3627029.00
EPSN balance_sheet (quarterly, 2025-06-30) — Receivables: 5496883.00
EPSN income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 6278234.00
EPSN income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 3201654.00
EPSN cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: 0.00
EPSN balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -38688953.00
EPSN income_statement (quarterly, 2025-06-30) — Salaries And Wages: 385838.00
EPSN cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 0.00
EPSN income_statement (quarterly, 2025-06-30) — Selling General And Administration: 1847716.00
EPSN balance_sheet (quarterly, 2025-06-30) — Share Issued: 22017405.00
EPSN income_statement (quarterly, 2025-06-30) — Special Income Charges: -2670000.00
EPSN cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 385838.00
EPSN balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 100190316.00
EPSN balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 100190316.00
EPSN income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -20188.77
EPSN income_statement (quarterly, 2025-06-30) — Tax Provision: 1837687.00
EPSN income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
EPSN balance_sheet (quarterly, 2025-06-30) — Total Assets: 123613668.00
EPSN balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 100190316.00
EPSN balance_sheet (quarterly, 2025-06-30) — Total Debt: 417307.00
EPSN balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 100190316.00
EPSN income_statement (quarterly, 2025-06-30) — Total Expenses: 8125950.00
EPSN balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 23423352.00
EPSN balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 107080340.00
EPSN balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 16019967.00
EPSN income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 828783.00
EPSN balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 1596958.00
EPSN income_statement (quarterly, 2025-06-30) — Total Unusual Items: -96137.00
EPSN income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -96137.00
EPSN balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 0.00
EPSN balance_sheet (quarterly, 2025-06-30) — Working Capital: 9129943.00
EPSN income_statement (quarterly, 2025-09-30) — +Operating Expense: 2844398.00
EPSN income_statement (quarterly, 2025-09-30) — +Total Revenue: 8981459.00
EPSN balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 2963805.00
EPSN balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 4296075.00
EPSN balance_sheet (quarterly, 2025-09-30) — Accrued Interest Receivable: 0.00
EPSN balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -171453204.00
EPSN balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 13267196.00
EPSN cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 0.00
EPSN income_statement (quarterly, 2025-09-30) — Basic Average Shares: 22017310.00
EPSN income_statement (quarterly, 2025-09-30) — Basic EPS: 0.05
EPSN cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 10377653.00
EPSN balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 494199.00
EPSN balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 387062.00
EPSN balance_sheet (quarterly, 2025-09-30) — Capital Stock: 116081031.00
EPSN balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 12766167.00
EPSN balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 12766167.00
EPSN cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -1378515.00
EPSN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -1378515.00
EPSN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 313755.00
EPSN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 3965950.00
EPSN cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -364431.00
EPSN cash_flow (quarterly, 2025-09-30) — Change In Income Tax Payable: -40235.00
EPSN cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -576932.00
EPSN cash_flow (quarterly, 2025-09-30) — Change In Payable: -404666.00
EPSN cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -404666.00
EPSN cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 0.00
EPSN cash_flow (quarterly, 2025-09-30) — Change In Receivables: 981684.00
EPSN cash_flow (quarterly, 2025-09-30) — Change In Tax Payable: -40235.00
EPSN cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 86.00
EPSN cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 981684.00
EPSN cash_flow (quarterly, 2025-09-30) — Changes In Cash: 2901190.00
EPSN balance_sheet (quarterly, 2025-09-30) — Common Stock: 116081031.00
EPSN cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -1378515.00
EPSN balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 100218033.00
EPSN cash_flow (quarterly, 2025-09-30) — Common Stock Payments: 0.00
EPSN income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 5531056.00
EPSN balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 2096675.00
EPSN balance_sheet (quarterly, 2025-09-30) — Current Assets: 19136523.00
EPSN balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 120799.00
EPSN balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 120799.00
EPSN balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 9924626.00
EPSN cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 103153.00
EPSN cash_flow (quarterly, 2025-09-30) — Deferred Tax: 103153.00
EPSN cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 2570462.00
EPSN income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 22159532.00
EPSN income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.05
EPSN income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 1072295.00
EPSN income_statement (quarterly, 2025-09-30) — EBIT: 1660458.00
EPSN income_statement (quarterly, 2025-09-30) — EBITDA: 4230920.00
EPSN cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -42676.00
EPSN cash_flow (quarterly, 2025-09-30) — End Cash Position: 13236167.00
EPSN cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -1378515.00
EPSN cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 4006826.00
EPSN cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -964307.00
EPSN income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 964307.00
EPSN balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 9864979.00
EPSN income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 2844398.00
EPSN balance_sheet (quarterly, 2025-09-30) — Gross PPE: 278135013.00
EPSN income_statement (quarterly, 2025-09-30) — Gross Profit: 3450403.00
EPSN balance_sheet (quarterly, 2025-09-30) — Hedging Assets Current: 889187.00
EPSN income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 0.00
EPSN cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 517860.00
EPSN balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 1556724.00
EPSN income_statement (quarterly, 2025-09-30) — Interest Expense: 11666.00
EPSN income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 11666.00
EPSN income_statement (quarterly, 2025-09-30) — Interest Income: 84894.00
EPSN income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 84894.00
EPSN cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 383.00
EPSN balance_sheet (quarterly, 2025-09-30) — Invested Capital: 100218033.00
EPSN cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 313755.00
EPSN balance_sheet (quarterly, 2025-09-30) — Land And Improvements: 637764.00
EPSN balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 266263.00
EPSN balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 266263.00
EPSN balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 3822030.00
EPSN cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
EPSN income_statement (quarterly, 2025-09-30) — Net Income: 1072295.00
EPSN income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 1072295.00
EPSN income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 1072295.00
EPSN income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 1072295.00
EPSN income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 1072295.00
EPSN cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 1072295.00
EPSN income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 1072295.00
EPSN income_statement (quarterly, 2025-09-30) — Net Interest Income: 73228.00
EPSN cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 0.00
EPSN income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 73228.00
EPSN cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 272879.00
EPSN balance_sheet (quarterly, 2025-09-30) — Net PPE: 106681809.00
EPSN cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 40876.00
EPSN balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 100218033.00